Differences in Myocardial Remodeling and Tissue Characteristics in Chronic Isolated Aortic and Mitral Regurgitation.


Journal

Circulation. Cardiovascular imaging
ISSN: 1942-0080
Titre abrégé: Circ Cardiovasc Imaging
Pays: United States
ID NLM: 101479935

Informations de publication

Date de publication:
03 2023
Historique:
pubmed: 8 3 2023
medline: 24 3 2023
entrez: 7 3 2023
Statut: ppublish

Résumé

The left ventricular hemodynamic load differs between aortic regurgitation (AR) and primary mitral regurgitation (MR). We used cardiac magnetic resonance to compare left ventricular remodeling patterns, systemic forward stroke volume, and tissue characteristics between patients with isolated AR and isolated MR. We assessed remodeling parameters across the spectrum of regurgitant volume. Left ventricular volumes and mass were compared against normal values for age and sex. We calculated forward stroke volume (planimetered left ventricular stroke volume-regurgitant volume) and derived a cardiac magnetic resonance-based systemic cardiac index. We assessed symptom status according to remodeling patterns. We also evaluated the prevalence of myocardial scarring using late gadolinium enhancement imaging, and the extent of interstitial expansion via extracellular volume fraction. We studied 664 patients (240 AR, 424 primary MR), median age of 60.7 (49.5-69.9) years. AR led to more pronounced increases in ventricular volume and mass compared with MR across the spectrum of regurgitant volume ( Cardiac magnetic resonance identified significant heterogeneity in remodeling patterns and tissue characteristics at matched degrees of AR and MR. Further research is needed to examine if these differences impact reverse remodeling and clinical outcomes after intervention.

Sections du résumé

BACKGROUND
The left ventricular hemodynamic load differs between aortic regurgitation (AR) and primary mitral regurgitation (MR). We used cardiac magnetic resonance to compare left ventricular remodeling patterns, systemic forward stroke volume, and tissue characteristics between patients with isolated AR and isolated MR.
METHODS
We assessed remodeling parameters across the spectrum of regurgitant volume. Left ventricular volumes and mass were compared against normal values for age and sex. We calculated forward stroke volume (planimetered left ventricular stroke volume-regurgitant volume) and derived a cardiac magnetic resonance-based systemic cardiac index. We assessed symptom status according to remodeling patterns. We also evaluated the prevalence of myocardial scarring using late gadolinium enhancement imaging, and the extent of interstitial expansion via extracellular volume fraction.
RESULTS
We studied 664 patients (240 AR, 424 primary MR), median age of 60.7 (49.5-69.9) years. AR led to more pronounced increases in ventricular volume and mass compared with MR across the spectrum of regurgitant volume (
CONCLUSIONS
Cardiac magnetic resonance identified significant heterogeneity in remodeling patterns and tissue characteristics at matched degrees of AR and MR. Further research is needed to examine if these differences impact reverse remodeling and clinical outcomes after intervention.

Identifiants

pubmed: 36880378
doi: 10.1161/CIRCIMAGING.122.014684
doi:

Substances chimiques

Contrast Media 0
Gadolinium AU0V1LM3JT

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e014684

Commentaires et corrections

Type : CommentIn

Auteurs

Maan Malahfji (M)

Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, TX (M.M., D.K., A.S., C.E.-T., B.T., D.D., V.C., M.J.R., M.Q., W.A.Z., D.J.S.).

Danai Kitkungvan (D)

Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, TX (M.M., D.K., A.S., C.E.-T., B.T., D.D., V.C., M.J.R., M.Q., W.A.Z., D.J.S.).
Division of Cardiology, Department of Internal Medicine, University of Texas McGovern School of Medicine, Houston (D.K.).

Alpana Senapati (A)

Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, TX (M.M., D.K., A.S., C.E.-T., B.T., D.D., V.C., M.J.R., M.Q., W.A.Z., D.J.S.).
Intermountain Medical Center, Salt Lake City, UT (A.S.).

Duc T Nguyen (DT)

Department of Pathology and Genomic Medicine, Houston Methodist Hospital Research Institute, TX (D.T.N., E.A.G.).

Carlos El-Tallawi (C)

Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, TX (M.M., D.K., A.S., C.E.-T., B.T., D.D., V.C., M.J.R., M.Q., W.A.Z., D.J.S.).

Bhupendar Tayal (B)

Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, TX (M.M., D.K., A.S., C.E.-T., B.T., D.D., V.C., M.J.R., M.Q., W.A.Z., D.J.S.).

Dany Debs (D)

Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, TX (M.M., D.K., A.S., C.E.-T., B.T., D.D., V.C., M.J.R., M.Q., W.A.Z., D.J.S.).

Valentina Crudo (V)

Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, TX (M.M., D.K., A.S., C.E.-T., B.T., D.D., V.C., M.J.R., M.Q., W.A.Z., D.J.S.).

Edward A Graviss (EA)

Department of Pathology and Genomic Medicine, Houston Methodist Hospital Research Institute, TX (D.T.N., E.A.G.).

Michael J Reardon (MJ)

Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, TX (M.M., D.K., A.S., C.E.-T., B.T., D.D., V.C., M.J.R., M.Q., W.A.Z., D.J.S.).

Miguel Quinones (M)

Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, TX (M.M., D.K., A.S., C.E.-T., B.T., D.D., V.C., M.J.R., M.Q., W.A.Z., D.J.S.).

William A Zoghbi (WA)

Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, TX (M.M., D.K., A.S., C.E.-T., B.T., D.D., V.C., M.J.R., M.Q., W.A.Z., D.J.S.).

Dipan J Shah (DJ)

Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, TX (M.M., D.K., A.S., C.E.-T., B.T., D.D., V.C., M.J.R., M.Q., W.A.Z., D.J.S.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH